End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.7 TWD | +0.79% | -1.55% | -27.84% |
May. 14 | Kuangli Bio-Tech Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 03 | Kuangli Bio-Tech Holdings Co., Ltd. announced a financing transaction | CI |
Sales 2022 | 342M 10.54M | Sales 2023 | 293M 9.03M | Capitalization | 1.01B 31.02M |
---|---|---|---|---|---|
Net income 2022 | -68M -2.09M | Net income 2023 | -104M -3.2M | EV / Sales 2022 | 4.01 x |
Net Debt 2022 | 208M 6.4M | Net Debt 2023 | 349M 10.75M | EV / Sales 2023 | 4.62 x |
P/E ratio 2022 |
-16.6
x | P/E ratio 2023 |
-9.67
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 86.4% |
1 day | +0.79% | ||
1 week | -1.55% | ||
1 month | -1.17% | ||
3 months | -21.36% | ||
6 months | -21.60% | ||
Current year | -27.84% |
Managers | Title | Age | Since |
---|---|---|---|
Ching Lien Chang
CEO | Chief Executive Officer | 54 | 19-04-02 |
Feng Chia Liu
DFI | Director of Finance/CFO | - | 15-06-26 |
Shu Hui Chen
BRD | Director/Board Member | - | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Tang Tsai
BRD | Director/Board Member | - | 13-12-05 |
Ching Lien Chang
CEO | Chief Executive Officer | 54 | 19-04-02 |
Shu Hui Chen
BRD | Director/Board Member | - | 02-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 12.7 | +0.79% | 54,010 |
24-05-30 | 12.6 | -1.56% | 35,056 |
24-05-29 | 12.8 | -.--% | 37,006 |
24-05-28 | 12.8 | -.--% | 37,007 |
24-05-27 | 12.8 | -0.78% | 61,008 |
End-of-day quote Taiwan S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-27.84% | 23.85M | |
+0.32% | 262B | |
+20.69% | 20.37B | |
-.--% | 19.29B | |
+17.52% | 12.64B | |
-16.59% | 8.94B | |
+33.93% | 8.62B | |
+9.55% | 5.93B | |
-12.08% | 3.92B | |
-16.83% | 3.84B |
- Stock Market
- Equities
- 6431 Stock